Bliss GVS Pharma Ltd.
BLISSGVS Share PricePharmaceuticals & Drugs
₹154.28
-1.6 (-1%)
As on September 8, 2025
Exchange Scrips: BSE506197NSEBLISSGVSISININE416D01022
Market Cap ₹ 1,631 Cr
P/E Ratio 19.28
Dividend Yield 0.32 %
Performance
Market performance
Open155.89
High157.29
Volumes2,54,639
Prev154.28
Low152.15
As on2025-09-08
Historical performance
1 Year High190.97
3 Year High190.97
5 Year High221
1 Year Low106.04
3 Year Low69.2
5 Year Low66.1
Fundamentals
Company Valuation
Market Cap (₹Cr)
1,631
Face Value (₹)
1
P/E Ratio
19.28
Dividend Yield
0.32 %
Investment Returns
1 Year
19.9%
3 Years
73.3%
5 Years
2.1%
10 Years
-9.8%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 156.94 | Bearish |
| 10-DMA | 157.99 | Bearish |
| 20-DMA | 164.28 | Bearish |
| 50-DMA | 162.63 | Bearish |
| 100-DMA | 146.2 | Bullish |
| 200-DMA | 145.44 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 8 | 7 | 7 | 7 | 7 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 8 | 7 | 7 | 7 | 7 |
| Public Investors | 46699 | 49510 | 49551 | 52930 | 44730 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 19.28.
- 3Y Stock Price CAGR of the stock is 21.6.
- The stock has a beta of 1.3.
- In the last financial year, the company had an EBITDA of ₹1632 Million.
- The company generated revenue of ₹8097 Million in the previous financial year.
Bliss GVS Pharma Ltd.
154.28-1.6 (-1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1176004.3
No. of Shares: 7623 (Approx)
Performance:17.6%
P/L: ₹176004.3
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent